Evolutionary Study Uncovers Potential Non-Addictive Pain Management Solutions
Recent study explores non-addictive alternatives for pain management by focusing on the evolution of a human protein responsible for cold sensations. By understanding the chemical sensing of cold versus physical sensation, researchers aim to develop side-effect-free pain medications, offering hope for effective relief without the risks of addiction or overdose.
FDA Approves First Menthol E-Cigarettes for Adult Sale
The FDA has approved the sale of the first menthol e-cigarettes for adults, recognizing their potential health benefits in reducing traditional cigarette smoking effects. Despite concerns, NJOY Holdings’ products have received authorization, but it’s crucial to note that FDA approval doesn’t mean they’re completely safe. With 27 approved products, the FDA is reviewing the vaping industry. While some criticize the decision, the FDA lifted marketing restrictions on Juul e-cigarettes and the Biden administration delayed a menthol tobacco ban. The approval of menthol e-cigarettes highlights the changing landscape of smoking cessation methods and regulations in the U.S.
New Menthol Derivatives Show Promise in Fighting Inflammation
Scientists have developed new compounds derived from menthol, known for its medicinal properties, to combat fat and inflammation. The study led by Professor Gen-ichiro Arimura from Tokyo University of Science discovered that menthyl esters of valine and isoleucine showed superior anti-inflammatory effects compared to menthol. Published in the Immunology journal, this research highlights the potential of these compounds in treating inflammatory conditions and opens up exciting possibilities in medicinal chemistry.